Advance Search
YU Kai, ZHANG Zhenxia, WANG Yuan. A comparative study on three antithrombotic treatments following percutaneous coronary intervention in patients with atrial fibrillation and coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 39-41. DOI: 10.7619/jcmp.202012011
Citation: YU Kai, ZHANG Zhenxia, WANG Yuan. A comparative study on three antithrombotic treatments following percutaneous coronary intervention in patients with atrial fibrillation and coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2020, 24(12): 39-41. DOI: 10.7619/jcmp.202012011
shu

A comparative study on three antithrombotic treatments following percutaneous coronary intervention in patients with atrial fibrillation and coronary heart disease

  • Department of Cardiovasology, Pucheng County Hospital, Pucheng, Shaanxi, 715500

More Information
  • Received Date: April 04, 2020
    Graphical Abstract
    • Abstract
  • Objective To compare the effect of three antithrombotic treatments following percutaneous coronary intervention(PCI)in patients with atrial fibrillation and coronary heart disease. Methods A total of 90 patients with atrial fibrillation and coronary heart disease treated by PCI were selected as study objects, and randomly divided into group Ⅰ(n=30, treated by warfarin combined with clopidogrel), group Ⅱ(n=30, treated by aspirin combined with clopidogrel), and group Ⅲ(n=30, treated by warfarin, aspirin combined with clopidogrel). The clinical efficacy and the attack of atrial fibrillation were compared. Results The total effective rate in the group Ⅲ was significantly higher than that in the group Ⅰ and the group Ⅱ(P<0.05); after intervention, the frequency of atrial fibrillation attack in the group Ⅲ was significantly lower than that in the group Ⅰ and the group Ⅱ, the duration of atrial fibrillation attack was significantly shorter than that in the group Ⅰ and the group Ⅱ, and the decreased degree of ST segment was significantly lower than that in the group Ⅰ and the group Ⅱ(P<0.05). Conclusion After PCI, patients with atrial fibrillation and coronary heart disease accepting warfarin, aspirin and clopidogrel have better clinical effect, and they have reduced frequency of atrial fibrillation attack, shortened onset duration, and decreased degree of ST segment depression.
    • FullText(HTML)
    • References (18)
  • 钱军, 陈建峰, 王丽洁, 等. 冠心病合并持续性心房颤动患者抗栓方案的研究[J]. 中华心律失常学杂志, 2018, 22(3): 215-221.
    栗醒. 高风险冠心病合并房颤抗凝与双联抗栓治疗的临床比较[J]. 数理医药学杂志, 2019, 32(6): 908-909.
    张智文, 杨海涛. 心房颤动患者经皮冠状动脉介入治疗后的抗栓疗法研究进展[J]. 中国心血管病研究, 2019(2): 114-117.
    陈淑霞, 李俊晓, 耿彦平, 等. 不同抗血小板治疗方案在CYP2C19*2等位基因型缺陷患者PCI术后疗效及安全性的比较[J]. 中国循证心血管医学杂志, 2018, 10(9): 1066-1069.
    豆瑾, 张杨, 党培玉, 等. 自我效能干预对冠心病合并2型糖尿病行冠状动脉介入治疗术后患者生命质量的影响[J]. 国际移植与血液净化杂志, 2019, 17(1): 33-34.
    吕洪伟, 赵伟涛, 罗世国, 等. 比伐卢定与替罗非班联合肝素在冠心病PCI术围手术期抗凝中效果比较[J]. 中国实用医刊, 2019, 46(2): 84-88.
    马腾龙, 韩斌. 丹参川芎嗪注射液联合利伐沙班对房颤合并冠心病患者疗效探讨[J]. 辽宁中医药大学学报, 2019, 21(3): 209-212.
    陈富军, 王冰, 牟海萍, 等. 老年心房颤动合并稳定性冠心病患者抗栓治疗的效果[J]. 中华老年医学杂志, 2018, 37(11): 1213-1217.
    周元, 许邦龙, 高峰. 心房颤动合并冠心病冠状动脉介入治疗术后达比加群酯抗凝治疗的有效性及安全性研究[J]. 安徽医药, 2019, 23(4): 657-661.
    晋章明, 余志杰. 冠心病合并房颤抗凝与双联抗血小板治疗的效果比较[J]. 血栓与止血学, 2019, 25(1): 60-62.
    Lam D H, Bell S M, Hira R S. Concomitant use of antiplatelets and anticoagulants in patients with coronary heart disease and atrial fibrillation: what do recent clinical trials teach us[J]. Curr Atheroscler Rep, 2018, 20(1): 4-10.
    周冰洁, 李玉梅, 罗向卫, 等. 不同强度华法林抗凝治疗高龄稳定性冠心病合并非瓣膜性心房颤动患者的临床研究[J]. 中国医学创新, 2019, 16(16): 46-49.
    朱艳琪. PCI术前强化他汀治疗对冠心病患者预后疗效及心肌缺血标志物的影响[J]. 中国实用医刊, 2018, 45(4): 120-123.
    Tikkanen E, Gustafsson S, Ingelsson E. Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK biobank study[J]. Circulation, 2018, 137(24): 2583-2591.
    周春娟, 王胜利, 朱继红. 阿托伐他汀强化治疗对冠心病患者PCI围术期血流动力学状态的影响及作用机制分析[J]. 药品评价, 2018, 15(11): 53-55.
    陈瑾瑾, 刘培延, 张倩, 等. 200例非瓣膜性心房颤动住院病人抗凝治疗现状及影响因素分析[J]. 安徽医药, 2019, 23(2): 406-411.
    黄俊, 叶玉苗, 王倩, 等. 高龄非瓣膜性心房颤动住院患者临床特征及抗栓治疗现状调查[J]. 岭南心血管病杂志, 2018, 24(3): 301-303.
    于萍. 丹红注射液联合华法林在房颤合并冠心病患者治疗中的作用[J]. 血栓与止血学, 2018, 24(3): 444-446.
    • Related Articles

  • Cited by

    Periodical cited type(10)

    1. 吴静，张颖，肖文焕. 团体心理剧疗法对围绝经期精神分裂症患者抑郁、自尊及应对能力的影响. 实用临床医药杂志. 2025(01): 125-129+143 . 本站查看
    2. 张颖，葛丽娜，曹雷，邹杰，周磊. 正念训练对慢性失眠障碍患者治疗效果及炎症因子的影响. 武警医学. 2024(01): 30-33 .
    3. 梁娜，郭雪丽，赵福涛. 基于IMB模型的睡眠心理行为护理在慢性失眠患者中的应用. 海南医学. 2024(10): 1489-1493 .
    4. 史亮亮，陈丽梅，陈丽. 柴胡温经汤加减治疗围绝经期肝郁阴虚夹瘀型顽固失眠症临床观察. 湖北中医药大学学报. 2024(03): 76-78 .
    5. 刘艳霞，单锋波. 正念减压疗法联合艾司唑仑片对更年期失眠患者睡眠质量及负面情绪的影响. 心理月刊. 2024(11): 137-139 .
    6. 王雅娟，杨洁. 分析步行运动联合正念干预对卵巢癌患者睡眠质量的影响. 世界睡眠医学杂志. 2024(05): 1102-1105 .
    7. 黄小丽，农秀明. 中医外治法治疗失眠临床研究进展. 广西中医药大学学报. 2024(04): 70-73 .
    8. 何兰英，何风英，李平，赵栋，孙岩. 基于正念的失眠认知疗法对老年非器质性失眠症患者正念、多导睡眠参数的影响. 临床误诊误治. 2024(12): 74-78 .
    9. 潘晨璐，孟萍. 脐灸联合穴位敷贴在围绝经期失眠患者中的应用效果. 中国当代医药. 2024(25): 79-82 .
    10. 李晶晶，宋玉娇，王婷，于洁，周敬，蒋桂军，李艳青. 睡眠健康教育联合自助式正念减压训练对围绝经期失眠患者的影响. 齐鲁护理杂志. 2024(21): 6-10 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(13)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return